Virtue Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $309K | Sell |
3,953
-251
| -6% | -$20.2K | 0.04% | 269 |
|
|
2026
Q1 | $360K | Buy |
4,204
+190
| +5% | +$18.2K | 0.05% | 231 |
|
|
2025
Q4 | $386K | Buy |
4,014
+465
| +13% | +$45.2K | 0.06% | 205 |
|
|
2025
Q3 | $298K | Buy |
3,549
+56
| +2% | +$5.15K | 0.05% | 240 |
|
|
2025
Q2 | $304K | Sell |
3,493
-1,711
| -33% | -$145K | 0.06% | 201 |
|
|
2025
Q1 | $468K | Buy |
5,204
+1,377
| +36% | +$123K | 0.05% | 271 |
|
|
2024
Q4 | $306K | Hold |
3,827
| – | – | 0.06% | 196 |
|
|
2024
Q3 | $345K | Sell |
3,827
-839
| -18% | -$70.6K | 0.07% | 186 |
|
|
2024
Q2 | $368K | Sell |
4,666
-39
| -0.8% | -$3.2K | 0.06% | 255 |
|
|
2024
Q1 | $381K | Sell |
4,705
-1,508
| -24% | -$129K | 0.07% | 252 |
|
|
2023
Q4 | $527K | Sell |
6,213
-1,470
| -19% | -$112K | 0.11% | 193 |
|
|
2023
Q3 | $667K | Hold |
7,683
| – | – | 0.11% | 168 |
|
|
2023
Q2 | $667K | Sell |
7,683
-448
| -6% | -$38.6K | 0.11% | 168 |
|
|
2023
Q1 | $732K | Buy |
8,131
+65
| +0.8% | +$5.3K | 0.12% | 141 |
|
|
2022
Q4 | $627K | Buy |
8,066
+5,416
| +204% | +$439K | 0.1% | 160 |
|
|
2022
Q3 | $214K | Sell |
2,650
-199
| -7% | -$17.9K | 0.03% | 236 |
|
|
2022
Q2 | $256K | Sell |
2,849
-5,467
| -66% | -$554K | 0.04% | 214 |
|
|
2022
Q1 | $923K | Buy |
8,316
+1,976
| +31% | +$209K | 0.15% | 175 |
|
|
2021
Q4 | $656K | Buy |
6,340
+1,866
| +42% | +$216K | 0.1% | 229 |
|
|
2021
Q3 | $561K | Sell |
4,474
-307
| -6% | -$39.7K | 0.1% | 229 |
|
|
2021
Q2 | $593K | Sell |
4,781
-327
| -6% | -$41.1K | 0.12% | 209 |
|
|
2021
Q1 | $603K | Sell |
5,108
-1,230
| -19% | -$144K | 0.14% | 185 |
|
|
2020
Q4 | $742K | Sell |
6,338
-3,004
| -32% | -$331K | 0.18% | 152 |
|
|
2020
Q3 | $971K | Sell |
9,342
-4,330
| -32% | -$435K | 0.24% | 121 |
|
|
2020
Q2 | $1.25M | Buy |
+13,672
| New | +$1.31M | 0.29% | 101 |
|
|
2020
Q1 | – | Sell |
-10,489
| Closed | -$1.19M | – | 141 |
|
|
2019
Q4 | $1.19M | Buy |
10,489
+359
| +4% | +$39.4K | 0.34% | 63 |
|
|
2019
Q3 | $1.1M | Sell |
10,130
-633
| -6% | -$66K | 0.36% | 95 |
|
|
2019
Q2 | $1.05M | Buy |
+10,763
| New | +$983K | 0.38% | 85 |
|
|
2018
Q4 | – | Sell |
-14,144
| Closed | -$1.39M | – | 181 |
|
|
2018
Q3 | $1.39M | Buy |
14,144
+9,026
| +176% | +$834K | 0.29% | 92 |
|
|
2018
Q2 | $438K | Buy |
5,118
+5,018
| +5,018% | +$419K | 0.21% | 147 |
|
|
2018
Q1 | $8K | Buy |
+100
| New | +$8.25K | ﹤0.01% | 392 |
|
Other funds holding MDT
MGP
Virtue Capital Management's MDT Position: Q2 2026 in Review
Virtue Capital Management reduced its Medtronic (MDT) stake by 6% in Q2 2026, selling an estimated $20.2K and leaving 3,953 shares worth $309K. The position accounts for 0.04% of the portfolio, ranked #269.
Virtue Capital Management first reported a position in MDT in Q1 2018 and has held it in 31 quarters since. The position peaked at $1.39M in Q3 2018. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Virtue Capital Management held 3,953 shares of Medtronic worth $309K as of Q2 2026.
- Virtue Capital Management sold 251 Medtronic shares in Q2 2026, an estimated $20.2K.
- Medtronic made up 0.04% of Virtue Capital Management's portfolio in Q2 2026, its #269 holding.
- Virtue Capital Management first reported a position in Medtronic in Q1 2018 and has held it in 31 quarters since.
- Virtue Capital Management's Medtronic position peaked at $1.39M in Q3 2018.
- 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.